136 related articles for article (PubMed ID: 32966477)
1. Rapid purification of lung cancer cells in pleural effusion through spiral microfluidic channels for diagnosis improvement.
Tsou PH; Chiang PH; Lin ZT; Yang HC; Song HL; Li BR
Lab Chip; 2020 Nov; 20(21):4007-4015. PubMed ID: 32966477
[TBL] [Abstract][Full Text] [Related]
2. High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients.
Tang Y; Wang Z; Li Z; Kim J; Deng Y; Li Y; Heath JR; Wei W; Lu S; Shi Q
Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2544-2549. PubMed ID: 28223509
[TBL] [Abstract][Full Text] [Related]
3. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
Huang MS; Tsai MS; Hwang JJ; Wang TH
Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
[TBL] [Abstract][Full Text] [Related]
4. Cytologic Investigations for the Diagnosis of Malignant Pleural Effusion in Non-small Cell Lung Cancer: State-of-the-art Review for Pulmonologists.
Shojaee S; Roy-Chowdhuri S; Safi J; Grosu HB
J Bronchology Interv Pulmonol; 2021 Oct; 28(4):310-321. PubMed ID: 34238837
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic utility of LUNX mRNA and VEGF mRNA in pleural fluid for differentiating benign from malignant origin.
Bao QL; Li J; Sun W; Jiang HG; Zhu LR; Wang Y
Jpn J Clin Oncol; 2014 Dec; 44(12):1198-205. PubMed ID: 25425729
[TBL] [Abstract][Full Text] [Related]
6. Pleural fluid mesothelin for the differential diagnosis of exudative pleural effusions.
Alemán C; Manuel Porcel J; Ma Segura R; Alegre J; Esquerda A; Ruiz E; Bielsa S; de Sevilla TF
Med Clin (Barc); 2009 Oct; 133(12):449-53. PubMed ID: 19783262
[TBL] [Abstract][Full Text] [Related]
7. Measurement and immunophenotyping of pleural fluid EpCAM-positive cells and clusters for the management of non-small cell lung cancer patients.
Thompson JC; Fan R; Black T; Yu GH; Savitch SL; Chien A; Yee SS; Sen M; Hwang WT; Katz SI; Feldman M; Vachani A; Carpenter EL
Lung Cancer; 2019 Jan; 127():25-33. PubMed ID: 30642547
[TBL] [Abstract][Full Text] [Related]
8. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
[TBL] [Abstract][Full Text] [Related]
9. Different expression of FoxM1 in human benign and malignant pleural effusion.
Tang Z; Li H; Zhu H; Bai C
Med Oncol; 2015 Jan; 32(1):312. PubMed ID: 25491139
[TBL] [Abstract][Full Text] [Related]
10. [Detection of carcinoembryonic antigen levels in pleural effusion and serum and their ratio for differential diagnosis of pleural effusion resulting from tuberculosis and lung cancer].
Li R; Gao Z; Dong K; Wang H; Zhang H
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):175-180. PubMed ID: 30890505
[TBL] [Abstract][Full Text] [Related]
11. Identification of 10 Candidate Biomarkers Distinguishing Tuberculous and Malignant Pleural Fluid by Proteomic Methods.
Lee CY; Hong JY; Lee MG; Suh IB
Yonsei Med J; 2017 Nov; 58(6):1144-1151. PubMed ID: 29047238
[TBL] [Abstract][Full Text] [Related]
12. Machine Learning Assisted Real-Time Label-Free SERS Diagnoses of Malignant Pleural Effusion due to Lung Cancer.
Perumal J; Lee P; Dev K; Lim HQ; Dinish US; Olivo M
Biosensors (Basel); 2022 Oct; 12(11):. PubMed ID: 36354448
[TBL] [Abstract][Full Text] [Related]
13. [Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion].
Liu YQ; Zhang HL; Gao WJ; Lan X; Yuan BJ; Zou JM
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):34-8. PubMed ID: 18302890
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of MUC1 and EpCAM mRNA as tumor markers in differentiating benign from malignant pleural effusion.
Sun W; Li J; Jiang HG; Ge LP; Wang Y
QJM; 2014 Dec; 107(12):1001-7. PubMed ID: 24939190
[TBL] [Abstract][Full Text] [Related]
15. Differentiating Malignant from Tubercular Pleural Effusion by Cancer Ratio Plus (Cancer Ratio: Pleural Lymphocyte Count).
Verma A; Dagaonkar RS; Marshall D; Abisheganaden J; Light RW
Can Respir J; 2016; 2016():7348239. PubMed ID: 28070157
[No Abstract] [Full Text] [Related]
16. Microfluidic purification and concentration of malignant pleural effusions for improved molecular and cytomorphological diagnostics.
Che J; Mach AJ; Go DE; Talati I; Ying Y; Rao J; Kulkarni RP; Di Carlo D
PLoS One; 2013; 8(10):e78194. PubMed ID: 24205153
[TBL] [Abstract][Full Text] [Related]
17. Metastatic renal cell carcinoma-associated pleural effusion after coronary artery bypass grafting.
Rowlands DM; Zasik JM; Reed JF
J Am Osteopath Assoc; 2004 May; 104(5):215-7. PubMed ID: 15176521
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum and pleural levels of soluble B7-H4 in lung cancer patients with pleural effusion.
Xu C; Qian L; Yu L; Zhang X; Wang Q
Biomarkers; 2015; 20(4):271-4. PubMed ID: 26301886
[TBL] [Abstract][Full Text] [Related]
19. Low-cost polymer-film spiral inertial microfluidic device for label-free separation of malignant tumor cells.
Wang C; Chen Y; Gu X; Zhang X; Gao C; Dong L; Zheng S; Feng S; Xiang N
Electrophoresis; 2022 Feb; 43(3):464-471. PubMed ID: 34611912
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
Dong J; Sun G; Zhu H
Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
